https://www.businesswire.com/news/home/20260326810310/en/Rubedo-Life-Sciences-Announces-Positive-Preliminary-Phase-1-Clinical-Trial-Results-for-Lead-Drug-Candidate-RLS-1496-in-Patients-with-Plaque-Psoriasis-Atopic-Dermatitis-and-Skin-Aging?_gl=1*z5pgy4*_gcl_au*OTAxNzMzNjMxLjE3NzAxNjAxMjU.*_ga*ODk1ODUyNjA5LjE3NzAxNjAxMjU.*_ga_ZQWF70T3FK*czE3NzQ1MjgyNDAkbzEwJGcxJHQxNzc0NTI4MjY3JGozMyRsMCRoMA
Rubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug...
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medic...
rubedo life sciences
https://www.businesswire.com/news/home/20241023573741/en/Rubedo-Life-Sciences-Announces-European-Expansion-Ahead-of-First-Clinical-Trial
Rubedo Life Sciences Announces European Expansion Ahead of First Clinical Trial
Rubedo announces European expansion ahead of company's EU-based clinical trial, and Italian investor CDP Venture Capital's participation in Series A
rubedo life sciencesannounceseuropean
https://www.businesswire.com/news/home/20240423279607/nl
Rubedo Life Sciences en Beiersdorf kondigen een meerjarig partnerschap aan om nieuwe...
Rubedo Life Sciences, een biotechnologiebedrijf gespecialiseerd in onderzoek naar cellulaire veroudering en antiveroudering, heeft vandaag een meerjarig stra...
rubedo life sciences